{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:01:50Z","timestamp":1791378110360,"version":"4.3.2"},"reference-count":40,"publisher":"American Veterinary Medical Association (AVMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p><jats:bold>Objective<\/jats:bold>\u2014To evaluate the effects of administration of a peripheral \u03b1<jats:sub>2<\/jats:sub>-adrenergic receptor antagonist (L-659,066), with and without concurrent administration of glycopyrrolate, on cardiopulmonary effects of medetomidine administration in dogs.<\/jats:p>\n<jats:p><jats:bold>Animals<\/jats:bold>\u20146 healthy adult dogs.<\/jats:p>\n<jats:p><jats:bold>Procedures<\/jats:bold>\u2014Dogs received saline (0.9% NaCl) solution (saline group), L-659,066 (group L), or L-659,066 with glycopyrrolate (group LG). These pretreatments were followed 10 minutes later by administration of medetomidine in a randomized crossover study. Hemodynamic measurements and arterial and mixed-venous blood samples for blood gas analysis were obtained prior to pretreatment, 5 minutes after pretreatment, and after medetomidine administration at intervals up to 60 minutes.<\/jats:p>\n<jats:p><jats:bold>Results<\/jats:bold>\u2014After pretreatment in the L and LG groups, heart rate, cardiac index, and partial pressure of oxygen in mixed-venous blood (PvO2) values were higher than those in the saline group. After medetomidine administration, heart rate, cardiac index, and PvO2 were higher and systemic vascular resistance, mean arterial blood pressure, and central venous pressure were lower in the L and LG groups than in the saline group. When the L and LG groups were compared, heart rate was greater at 5 minutes after medetomidine administration, mean arterial blood pressure was greater at 5 and 15 minutes after medetomidine administration, and central venous pressure was lower during the 60-minute period after medetomidine administration in the LG group.<\/jats:p>\n<jats:p><jats:bold>Conclusions and Clinical Relevance<\/jats:bold>\u2014Administration of L-659,066 prior to administration of medetomidine reduced medetomidine-induced cardiovascular changes in healthy dogs. No advantage was detected with concurrent administration of L-659,066 and glycopyrrolate.<\/jats:p>","DOI":"10.2460\/ajvr.69.6.728","type":"journal-article","created":{"date-parts":[[2008,6,2]],"date-time":"2008-06-02T12:26:36Z","timestamp":1212409596000},"page":"728-736","source":"Crossref","is-referenced-by-count":55,"title":["Effects of a peripheral \u03b12 adrenergic-receptor antagonist on the hemodynamic changes induced by medetomidine administration in conscious dogs"],"prefix":"10.2460","volume":"69","author":[{"given":"Saad S.","family":"Enouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn L.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne N.","family":"McDonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Lynne","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J. Teixeira","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Acta Vet Scand","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/BF03548031","article-title":"Clinical evaluation of medetomidine, a novel sedative and analgesic drug for dogs and cats","volume":"30","author":"Vaha-Vahe","year":"1989"},{"key":"ref2","series-title":"J Vet Pharmacol Ther","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-2885.1989.tb00664.x","article-title":"Sedative and analgesic effects of medetomidine in dogs","volume":"12","author":"Vainio","year":"1989"},{"key":"ref3","series-title":"Vet Surg","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1532-950X.1998.tb00539.x","article-title":"Hemodynamic effects of medetomidine in the dog: a dose titration study","volume":"27","author":"Pypendop","year":"1998"},{"key":"ref4","series-title":"J Small Anim Pract","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1748-5827.1989.tb01575.x","article-title":"Medetomidine, a new sedative-analgesic for use in the dog and its reversal with atipamezole","volume":"30","author":"Clarke","year":"1989"},{"key":"ref5","series-title":"Acta Vet Scand Suppl","first-page":"39","article-title":"Cardiovascular actions of medetomidine and their reversal by atipamezole","volume":"85","author":"Savola","year":"1989"},{"key":"ref6","series-title":"Acta Vet Scand","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/BF03548016","article-title":"Cardiovascular and respiratory effects of medetomidine in dogs and influence of anticholinergics","volume":"30","author":"Vainio","year":"1989"},{"key":"ref7","series-title":"Acta Vet Scand Suppl","first-page":"71","article-title":"Action of the stereoisomers of medetomidine, in halothane-anesthetized dogs","volume":"85","author":"Vickery","year":"1989"},{"key":"ref8","series-title":"Am J Vet Res","first-page":"1148","article-title":"Cardiorespiratory effects of a combination of medetomidine, midazolam, and butorphanol in dogs","volume":"60","author":"Pypendop","year":"1999"},{"key":"ref9","series-title":"Am J Vet Res","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2460\/ajvr.2004.65.931","article-title":"Comparative cardiovascular, analgesic, and sedative effects of medetomidine, medetomidine-hydromorphone, and medetomidine-butorphanol in dogs","volume":"65","author":"Kuo","year":"2004"},{"key":"ref10","series-title":"J Vet Pharmacol Ther","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1365-2885.2000.00245.x","article-title":"Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs","volume":"23","author":"Kuusela","year":"2000"},{"key":"ref11","series-title":"J Vet Med Sci","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1292\/jvms.57.99","article-title":"Cardiopulmonary effects of medetomidine, medetomidine-midazolam and medetomidine-midazolam-atipamezole in dogs","volume":"57","author":"Hayashi","year":"1995"},{"key":"ref12","series-title":"Vet Anaesth Analg","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1467-2987.2004.00164.x","article-title":"Cardiopulmonary effects of medetomidine, oxymorphone, or butorphanol in selegiline-treated dogs","volume":"31","author":"Dodam","year":"2004"},{"key":"ref13","series-title":"Acta Vet Scand Suppl","first-page":"179","article-title":"The use of medetomidine\/fentanyl combinations in dogs","volume":"85","author":"England","year":"1989"},{"key":"ref14","series-title":"Vet Ther","first-page":"51","article-title":"Oxygenation in medetomidine-sedated dogs with and without 100% oxygen insufflation","volume":"8","author":"Ko","year":"2007"},{"key":"ref15","series-title":"Am J Vet Res","first-page":"724","article-title":"Hemodynamic effects of medetomidine-midazolam-butorphanol and medetomidine-midazolam-buprenorphine combinations and reversibility by atipamezole in dogs","volume":"57","author":"Pypendop","year":"1996"},{"key":"ref16","series-title":"J Am Anim Hosp Assoc","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5326\/15473317-34-4-325","article-title":"Morbidity and mortality associated with anesthetic management in small animal veterinary practice in Ontario","volume":"34","author":"Dyson","year":"1998"},{"key":"ref17","series-title":"J Assoc Vet Anaesth","first-page":"4","article-title":"A survey of anaesthesia in small animal practice: AVA\/BSAVA report","volume":"17","author":"Clarke","year":"1990"},{"key":"ref18","series-title":"Prog Neuropsychopharmacol Biol Psychiatry","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0278-5846(89)90051-1","article-title":"Medetomidine\u2014a novel alpha 2-adrenoceptor agonist: a review of its pharmacodynamic effects","volume":"13","author":"Scheinin","year":"1989"},{"key":"ref19","series-title":"J Pharmacol Exp Ther","first-page":"690","article-title":"Hemodynamic and sedative effects of dexmedetomidine in dog","volume":"263","author":"Bloor","year":"1992"},{"key":"ref20","series-title":"Vet Anaesth Analg","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1467-2987.2001.00056.x","article-title":"The cardiopulmonary effects of romifidine in dogs with and without prior or concurrent administration of glycopyrrolate","volume":"29","author":"Sinclair","year":"2002"},{"key":"ref21","series-title":"Anesthesiology","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/00000542-199011000-00020","article-title":"Effects of dexmedetomidine on contractility, relaxation, and intracellular calcium transients of isolated ventricular myocardium","volume":"73","author":"Housmans","year":"1990"},{"key":"ref22","series-title":"J Cardiothorac Vasc Anesth","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/1053-0770(92)90006-S","article-title":"Effect of dexmedetomidine, an alpha 2-adrenergic agonist, in the isolated heart","volume":"6","author":"Flacke","year":"1992"},{"key":"ref23","series-title":"Am J Vet Res","first-page":"136","article-title":"Alpha 2-adrenergic receptor agonist effects on supraventricular and ventricular automaticity in dogs with complete atrioventricular block","volume":"54","author":"Day","year":"1993"},{"key":"ref24","series-title":"Vet Surg","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1532-950X.1995.tb01343.x","article-title":"The effects of medetomidine on cardiac contractility in autonomically blocked dogs","volume":"24","author":"de Morais","year":"1995"},{"key":"ref25","series-title":"J Cardiothorac Vasc Anesth","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1053-0770(98)90197-5","article-title":"A novel alpha 2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs","volume":"12","author":"Pagel","year":"1998"},{"key":"ref26","series-title":"Vet Rec","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/vr.129.14.310","article-title":"Effects of anticholinergic treatment on the cardiac and respiratory systems in dogs sedated with medetomidine","volume":"129","author":"Short","year":"1991"},{"key":"ref27","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2460\/javma.2001.218.52","article-title":"Effects of preemptive atropine administration on incidence of medetomidine-induced bradycardia in dogs","volume":"218","author":"Ko","year":"2001"},{"key":"ref28","series-title":"Vet Rec","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/vr.138.1.11","article-title":"Cardiopulmonary effects of combinations of medetomidine hydrochloride and atropine sulphate in dogs","volume":"138","author":"Alibhai","year":"1996"},{"key":"ref29","series-title":"Res Vet Sci","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0034-5288(98)90167-9","article-title":"Characterisation of the cardiovascular pharmacology of medetomidine in the horse and sheep","volume":"65","author":"Bryant","year":"1998"},{"key":"ref30","series-title":"J Pharmacol Exp Ther","first-page":"32","article-title":"A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066","volume":"245","author":"Clineschmidt","year":"1988"},{"key":"ref31","series-title":"Can J Comp Med","first-page":"112","article-title":"A preliminary investigation on the use of thermodilution and echocardiography as an assessment of cardiac function in the cat","volume":"47","author":"Allen","year":"1983"},{"key":"ref32","series-title":"Can J Vet Res","first-page":"107","article-title":"Comparative hemodynamic effects of halothane and halothane-acepromazine at equipotent doses in dogs","volume":"55","author":"Boyd","year":"1991"},{"key":"ref33","series-title":"Comp Med","first-page":"156","article-title":"Reference cardiopulmonary values in normal dogs","volume":"55","author":"Haskins","year":"2005"},{"key":"ref34","series-title":"Eur J Pharmacol","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0014-2999(89)90133-7","article-title":"Effects of a peripherally acting alpha 2-adrenoceptor antagonist (L-659,066) on hemodynamics and plasma levels of catechols in conscious rats","volume":"170","author":"Szemeredi","year":"1989"},{"key":"ref35","series-title":"Br J Clin Pharmacol","first-page":"521","article-title":"A preliminary, clinical pharmacological assessment of L-659,066, a novel alpha 2-adrenoceptor antagonist","volume":"34","author":"Schafers","year":"1992"},{"key":"ref36","series-title":"J Cardiothorac Vasc Anesth","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/1053-0770(93)90117-4","article-title":"Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog","volume":"7","author":"Flacke","year":"1993"},{"key":"ref37","series-title":"Can J Vet Res","first-page":"99","article-title":"Comparison of medetomidine and fentanyl-droperidol in dogs: sedation, analgesia, arterial blood gases and lactate levels","volume":"57","author":"Pettifer","year":"1993"},{"key":"ref38","series-title":"Acta Vet Scand Suppl","first-page":"65","article-title":"The effects of medetomidine, an alpha 2-adrenergic agonist, on ventilatory drive in the dog","volume":"85","author":"Bloor","year":"1989"},{"key":"ref39","series-title":"J Am Vet Med Assoc","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.2460\/javma.2000.216.1578","article-title":"Sedative and cardiorespiratory effects of medetomidine, medetomidine-butorphanol, and medetomidine-ketamine in dogs","volume":"216","author":"Ko","year":"2000"},{"key":"ref40","series-title":"Vet Rec","first-page":"447","article-title":"Reversal of medetomidine-induced cardiovascular and respiratory changes with atipamezole in dogs","volume":"127","author":"Vainio","year":"1990"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/69\/6\/ajvr.69.6.728.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/69\/6\/ajvr.69.6.728.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/69\/6\/ajvr.69.6.728.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:47:56Z","timestamp":1741351676000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/69\/6\/ajvr.69.6.728.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":40,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.69.6.728","relation":{},"ISSN":["0002-9645"],"issn-type":[{"value":"0002-9645","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}